(Q37761859)

22 August 2017

1 reference

title

Intranasal steroids in the treatment of allergy-induced rhinorrhea (English)

1 reference

22 August 2017

Robert A Nathan

1

1 reference

22 August 2017

language of work or name

1 reference

1 August 2011

1 reference

Clinical Reviews in Allergy & Immunology

22 August 2017

published in

1 reference

22 August 2017

volume

41

1 reference

22 August 2017

issue

1

1 reference

22 August 2017

page(s)

89-101

1 reference

Allergic rhinitis and its impact on asthma

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Impact of nasal congestion on quality of life and work productivity in allergic rhinitis: findings from a large online survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Classification and management of allergic rhinitis patients in general practice during pollen season

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Evaluation of nasal cytology in subjects with chronic rhinitis: a 7-year study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

BSACI guidelines for the management of allergic and non-allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Relief of cough and nasal symptoms associated with allergic rhinitis by mometasone furoate nasal spray

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Chronic upper airway cough syndrome secondary to rhinosinus diseases (previously referred to as postnasal drip syndrome): ACCP evidence-based clinical practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Findings from a 1000-patient internet-based survey assessing the impact of morning symptoms on individuals with allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Multicenter study on the prevalence of perennial allergic rhinitis and allergy-associated disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Pathogenesis of allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Allergic rhinitis and asthma: inflammation in a one-airway condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Overview of allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Impact and modulation of nasal obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Mode of action of intranasal corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

The role of histamine in allergic disease: re-appraisal of its inflammatory potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

The pathophysiology, clinical impact, and management of nasal congestion in allergic rhinitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Regulatory effect of histamine H1 receptor antagonist on the expression of messenger RNA encoding CC chemokines in the human nasal mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Intranasal mometasone furoate reduces late-phase inflammation after allergen challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

The inhibitory effects of topically active glucocorticoids on IL-4, IL-5, and interferon-gamma production by cultured primary CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Activation of guinea pig lymphocytes and mast cells by grain-dust extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Intranasal corticosteroids reduce ocular symptoms associated with allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis. Meta-analysis of randomized, double-blind, placebo-controlled, clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Onset of action of mometasone furoate nasal spray (NASONEX) in seasonal allergic rhinitis

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

21 January 2018

12 December 2020

Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Efficacy and safety of ciclesonide, 200 microg once daily, for the treatment of perennial allergic rhinitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Effect of once-daily fluticasone furoate nasal spray on nasal symptoms in adults and adolescents with perennial allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

A placebo‐controlled study of fluticasone propionate aqueous nasal spray and beclomethasone dipropionate in perennial rhinitis: efficacy in allergic and non‐allergic perennial rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Fluticasone furoate nasal spray: effective monotherapy for symptoms of perennial allergic rhinitis in adults/adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

The diagnosis and management of rhinitis: an updated practice parameter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Comparison of ipratropium bromide 0.03% with beclomethasone dipropionate in the treatment of perennial rhinitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Ipratropium bromide aqueous nasal spray for patients with perennial allergic rhinitis: a study of its effect on their symptoms, quality of life, and nasal cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

The role of antileukotriene therapy in seasonal allergic rhinitis: a systematic review of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Comparison of intranasal corticosteroids and antihistamines in allergic rhinitis: a review of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Effects of intranasal fluticasone and salmeterol on allergen-induced nasal responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Severity and impairment of allergic rhinitis in patients consulting in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Nasal corticosteroids, first choice in moderate to severe allergic rhinitis. What prevents general practitioners from using them?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Mometasone furoate nasal spray: a review of safety and systemic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Safety of intranasal corticosteroids in acute rhinosinusitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Sedation with "non-sedating" antihistamines: four prescription-event monitoring studies in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine: a prescription-event monitoring study in England

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Clinical prescribing of allergic rhinitis medication in the preschool and young school-age child: what are the options?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8206-2

Effect of mometasone furoate on early and late phase inflammation in patients with seasonal allergic rhinitis

21 January 2018

1 reference

12 December 2020

Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology

1 reference

12 December 2020

The anticholinergic agent, ipratropium bromide, is useful in the treatment of rhinorrhea associated with perennial allergic rhinitis

1 reference

12 December 2020

Characteristics of intermittent and persistent allergic rhinitis: DREAMS study group

1 reference

12 December 2020

Prevalence of allergic rhinitis and nasal smear eosinophilia in 11- to 15 yr-old children in Shiraz

1 reference

12 December 2020

Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge

1 reference

12 December 2020

International Primary Care Respiratory Group (IPCRG) Guidelines: management of allergic rhinitis

1 reference

12 December 2020

Fluticasone propionate: an effective alternative treatment for seasonal allergic rhinitis in adults and adolescents

1 reference

12 December 2020

Cerebrospinal fluid rhinorrhoea: diagnosis and management.

1 reference

12 December 2020

Efficacy and safety of ciclesonide nasal spray for the treatment of seasonal allergic rhinitis

1 reference

12 December 2020

Long-term safety and efficacy of intranasal ciclesonide in adult and adolescent patients with perennial allergic rhinitis

1 reference

12 December 2020

Long-term treatment of perennial allergic rhinitis with ipratropium bromide nasal spray 0.06%

1 reference

12 December 2020

Physician prescribing practices: the role of patient preference in the selection of nasal steroids

1 reference

12 December 2020

Intranasal steroids inhibit seasonal increases in ragweed-specific immunoglobulin E antibodies

1 reference

12 December 2020

Rupatadine: a new selective histamine H1 receptor and platelet-activating factor (PAF) antagonist. A review of pharmacological profile and clinical management of allergic rhinitis

1 reference

12 December 2020

Postnasal drip syndrome. Two hundred years of controversy between UK and USA.

1 reference

12 December 2020

Mode of action of a topical steroid on immediate phase reaction after antigen challenge and nonspecific nasal hyperreactivity in nasal allergy

1 reference

12 December 2020

The anticholinergic treatment of allergic perennial rhinitis

1 reference

12 December 2020

A survey of the burden of allergic rhinitis in Europe

1 reference

12 December 2020

Long-term effects of corticosteroid nasal spray on nasal inflammatory cells in patients with perennial allergic rhinitis

1 reference

12 December 2020

Mometasone furoate nasal spray reduces the ocular symptoms of seasonal allergic rhinitis

1 reference

12 December 2020

Treatment of allergic rhinitis: an evidence-based evaluation of nasal corticosteroids versus nonsedating antihistamines

1 reference

12 December 2020

Once-daily mometasone furoate aqueous nasal spray (Nasonex) in seasonal allergic rhinitis: an active- and placebo-controlled study

1 reference

12 December 2020

A double-blind, placebo-controlled comparison of treatment with fluticasone propionate and levocabastine in patients with seasonal allergic rhinitis. FLNCO2 Italian Study Group

1 reference

12 December 2020

Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. 194-079 Study Group

1 reference

12 December 2020

The role of leukotriene D4 in allergic rhinitis.

1 reference

12 December 2020

Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment

1 reference

12 December 2020

Once daily fluticasone propionate is as effective for perennial allergic rhinitis as twice daily beclomethasone diproprionate

1 reference

12 December 2020

Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitis

1 reference

12 December 2020

10.1007/S12016-010-8206-2

Identifiers

DOI

1 reference

22 August 2017

1 reference